BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6658021)

  • 1. [Experimental and clinical studies of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan(99mTc-PMT)].
    Yoshida H; Kanamori I; Nakano S; Takeda I; Yasuda E; Matsuo S; Ichikawa H; Kimura T; Iwata F; Higuchi C
    Radioisotopes; 1983 Jul; 32(7):340-43. PubMed ID: 6658021
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation on hepatobiliary scintigraphy with 99mTc(Sn)-N-pyridoxyl-5-methyltryptophan.
    Yamashita M; Watanabe A; Miyazaki T; Nakajima E; Okuno T
    Radioisotopes; 1982 Dec; 31(12):657-9. PubMed ID: 7170355
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT).
    Sugimura K; Nishiyama S; Narabayashi I
    Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyl tryptophan (99mTc-PMT)].
    Kuwabara Y; Oshiumi Y; Ichiya Y; Wada M; Shiozaki H; Hirata N; Matsuura K
    Radioisotopes; 1983 Jan; 32(1):26-9. PubMed ID: 6856881
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical efficacy of hepatobiliary scintigraphy using 99m Tc-N-pyridoxyl-5-methyltryptophan (PMT)].
    Aburano T; Ohguchi M; Kuwajima A; Tonami N; Hisada K
    Kaku Igaku; 1983 Apr; 20(3):353-60. PubMed ID: 6632363
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the clinical usefulness of 99mTc-N-Pyridoxyl-5-methyltryptophan as a hepatobiliary scintigraphic agent].
    Watanabe Y; Sugimoto S; Kobori K; Katsuyama N; Zeniya M; Kawakami K
    Kaku Igaku; 1982 Dec; 19(10):1589-93. PubMed ID: 7169693
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatobiliary scintigraphy and liver function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT)].
    Sugimura K; Narabayashi I; Nabeshima K; Ishido N; Hashimoto K; Yamasaki K; Hamada T; Sugimura C; Suematsu T; Inoue Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1205-13. PubMed ID: 6672750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of 99mTc-N-pyridoxyl-5-methyltryptophan hepatobiliary scintigraphy in hepatocellular carcinoma].
    Kashiwagi T; Azuma M; Matsuda H; Yoshioka H; Ishizu H; Mitsutani N; Koizumi T; Kobayashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2061-7. PubMed ID: 2419606
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic and clinical evaluation of hepatobiliary function by 99mTc-pyridoxyl-5-methyl-tryptophan].
    Morimoto Y; Tochio H; Yamada A; Hamasaki T; Saiki Y; Bito S; Ito H; Ikekubo K; Senda M; Kudo M
    Kaku Igaku; 1983 Nov; 20(9):1361-9. PubMed ID: 6676522
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of acute cholecystitis using hepatobiliary scintigraphy with 99mTc-PMT].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H; Shikata J; Kuniyasu Y; Higashi S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Jul; 45(7):1032-8. PubMed ID: 4080522
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
    J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
    Hayakawa T; Katagiri K; Shiraka S; Nakai T; Takeshima A; Kawamura Y; Ohnishi H; Hoshino M; Tsukada K; Miyani M
    Nihon Shokakibyo Gakkai Zasshi; 1988 Nov; 85(11):2389-95. PubMed ID: 3221493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma].
    Hasegawa Y; Nakano S; Noguchi A; Hashizume T; Ibuka K; Sasaki Y; Imaoka M; Kozima J; Ishigami S
    Kaku Igaku; 1983 Nov; 20(9):1355-9. PubMed ID: 6328071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatobiliary functions in primary biliary cirrhosis--assessment with 99mTc-PMT hepatobiliary scintigraphy].
    Imai Y
    Kaku Igaku; 1994 Mar; 31(3):249-56. PubMed ID: 8176863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of hepatic function by hepatobiliary scintigraphy using factor analysis].
    Shimomura O; Takahashi M; Tsuji A; Takagi Y; Tomiguchi S; Koga Y; Kojima A; Matsumoto M; Hara M; Hirota Y
    Kaku Igaku; 1989 Feb; 26(2):145-53. PubMed ID: 2733200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of 99mTc-labeled hepatobiliary scanning agent, 99mTc-(p-butyl)IDA (author's transl)].
    Kawaguchi S; Iio M; Chiba K; Yamada H; Murata H; Noguchi M; Ohtake E; Toyama H
    Kaku Igaku; 1980 Sep; 17(8):943-50. PubMed ID: 6894316
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the hepatobiliary system using 99mTc-p-butyl-IDA].
    Zubovskiĭ GA; Ogneva TV
    Med Radiol (Mosk); 1982 Jan; 27(1):28-31. PubMed ID: 6977080
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H
    Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamental and clinical evaluation of Tc-99m-(p-butyl) IDA for hepatobiliary scintigraphy (author's transl)].
    Fukuchi M; Kido A; Tachibana K; Morita T; Hyodo K; Onoue K; Hamada K; Maeda Y; Nagai K
    Kaku Igaku; 1980 Sep; 17(8):981-90. PubMed ID: 6894318
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver and hepatobiliary scintigraphy in children.
    Padhy AK; Basu AK
    Indian Pediatr; 1982 Mar; 19(3):249-63. PubMed ID: 6754605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.